 Botulinum Toxins, Type A
"Botulinum Toxins, Type A" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A serotype of botulinum toxins that has specificity for cleavage of SYNAPTOSOMAL-ASSOCIATED PROTEIN 25.
| Descriptor ID |
D019274
|
| MeSH Number(s) |
D08.811.277.656.300.480.153.100 D08.811.277.656.675.374.153.100 D12.776.097.156.100 D23.946.123.179.050
|
| Concept/Terms |
Botulinum Toxins, Type A- Botulinum Toxins, Type A
- Botulinum Neurotoxin A
- Neurotoxin A, Botulinum
- Clostridium botulinum A Toxin
- Clostridium Botulinum Toxin Type A
- Botulinum A Toxin
- Toxin, Botulinum A
- Botulinum Toxin Type A
|
Below are MeSH descriptors whose meaning is more general than "Botulinum Toxins, Type A".
Below are MeSH descriptors whose meaning is more specific than "Botulinum Toxins, Type A".
This graph shows the total number of publications written about "Botulinum Toxins, Type A" by people in this website by year, and whether "Botulinum Toxins, Type A" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 3 | 0 | 3 | | 2009 | 1 | 0 | 1 | | 2010 | 1 | 0 | 1 | | 2011 | 2 | 0 | 2 | | 2012 | 4 | 0 | 4 | | 2013 | 3 | 0 | 3 | | 2014 | 0 | 1 | 1 | | 2015 | 1 | 0 | 1 | | 2016 | 2 | 0 | 2 | | 2017 | 7 | 0 | 7 | | 2020 | 4 | 0 | 4 | | 2021 | 2 | 0 | 2 | | 2022 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Botulinum Toxins, Type A" by people in Profiles.
-
Daniel SJ, Fayoux P, Bateman N, Boudewyns A, Brigger M, Chan CY, Chan K, Cheng A, Conley S, Kubba H, Lambert EM, Muntz H, Nuss R, Russell J, Rutter M, Schwarz Y, Spratley J, Thevasagayam R, Thompson D, Valika T, Wyatt M. Comprehensive management of anterior drooling: An International Pediatric Otolaryngology Group (IPOG) consensus statement. Int J Pediatr Otorhinolaryngol. 2023 May; 168:111500.
-
Gayou N, Plumb ID, Edwards L, Pomeroy M, Herlihy RK, Johnson R, Pattison K, Dykes J, G?mez GA, Jervis RH. Outbreak of Foodborne Botulism Associated with a Commercially Produced Multipack Potato Product, Colorado: September 2019. Foodborne Pathog Dis. 2022 10; 19(10):713-715.
-
Montminy T, Belkind-Gerson J, Kilgore A, Tran P, Mark JA. Evaluating the Accuracy of Anal Botulinum Toxin Injection in Children With Constipation Using Endoscopic Ultrasound. J Pediatr Gastroenterol Nutr. 2022 04 01; 74(4):e98.
-
Wissel J, Cam?es-Barbosa A, Comes G, Althaus M, Scheschonka A, Simpson DM. Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis. Toxins (Basel). 2021 Dec 11; 13(12).
-
Mountan S, Duncan C, Hansen C. Resolution of prosthesis-related residual limb wounds after botulinum toxin for secondary hyperhidrosis. PM R. 2022 08; 14(8):1026-1028.
-
Jog M, Lee J, Scheschonka A, Chen R, Ismail F, Boulias C, Hobson D, King D, Althaus M, Simon O, Dersch H, Frucht S, Simpson DM. Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study. Toxins (Basel). 2020 Dec 20; 12(12).
-
Bensmail D, Wissel J, Laffont I, Simon O, Scheschonka A, Flatau-Baqu? B, Dressler D, Simpson DM. Efficacy of incobotulinumtoxinA for the treatment of adult lower-limb post-stroke spasticity, including pes equinovarus. Ann Phys Rehabil Med. 2021 Mar; 64(2):101376.
-
Wissel J, Bensmail D, Scheschonka A, Flatau-Baqu? B, Simon O, Althaus M, Simpson DM. Post hoc analysis of the improvement in shoulder spasticity and safety observed following treatment with incobotulinumtoxinA. J Rehabil Med. 2020 Mar 18; 52(3):jrm00028.
-
Fheodoroff K, Rekand T, Medeiros L, Ko?mehl P, Wissel J, Bensmail D, Scheschonka A, Flatau-Baqu? B, Simon O, Dressler D, Simpson DM. Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA. Health Qual Life Outcomes. 2020 Mar 04; 18(1):51.
-
Pandey S, Srivanitchapoom P, Kirubakaran R, Berman BD. Botulinum toxin for motor and phonic tics in Tourette's syndrome. Cochrane Database Syst Rev. 2018 Jan 05; 1:CD012285.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|